Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

At the IEEE International Electron Devices Meeting (IEDM 2025), imec has announced a breakthrough in semiconductor-based biosensing: the first wafer-scale fabrication of solid-state nanopores using ...

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...

Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...

Avance Biosciences has opened a 75,000-square-foot biomanufacturing facility in Northwest Houston. The facility will support ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

The custom antibody market is projected to grow at a CAGR of roughly 10% over the forecast period. This expansion is fueled ...

Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI).